相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。RUNX1/AML1 mutant collaborates with BMI1 overexpression in the development of human and murine myelodysplastic syndromes
Yuka Harada et al.
BLOOD (2013)
The myelodysplastic syndrome as a prototypical epigenetic disease
Jean-Pierre J. Issa
BLOOD (2013)
TP53 mutations in myelodysplastic syndrome are strongly correlated with aberrations of chromosome 5, and correlate with adverse prognosis
Austin G. Kulasekararaj et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Reciprocal translocations in myelodysplastic syndromes and chronic myelomonocytic leukemias: Review of 5,654 patients with an evaluable karyotype
Dolors Costa et al.
GENES CHROMOSOMES & CANCER (2013)
Stem cell maintenance and disease progression in chronic myeloid leukemia
Takahiro Ito
INTERNATIONAL JOURNAL OF HEMATOLOGY (2013)
BCR-ABL1 kinase inhibits uracil DNA glycosylase UNG2 to enhance oxidative DNA damage and stimulate genomic instability
A. Slupianek et al.
LEUKEMIA (2013)
SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations
M. Meggendorfer et al.
LEUKEMIA (2013)
Prognosis of secondary acute myeloid leukemia
Matteo Giovanni Della Porta
LEUKEMIA RESEARCH (2013)
Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes
Wendy W. Pang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Clinical significance of genetic aberrations in secondary acute myeloid leukemia
Jelena D. Milosevic et al.
AMERICAN JOURNAL OF HEMATOLOGY (2012)
Functional features of RUNX1 mutants in acute transformation of chronic myeloid leukemia and their contribution to inducing murine full-blown leukemia
Li-Juan Zhao et al.
BLOOD (2012)
ETV6 deletion is a common additional abnormality in patients with myelodysplastic syndromes or acute myeloid leukemia and monosomy 7
Meaghan Wall et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Acetylation-dependent nuclear arrangement and recruitment of BMI1 protein to UV-damaged chromatin
Gabriela Sustackova et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
c-Myb and its target Bmi1 are required for p190BCR/ABL leukemogenesis in mouse and human cells
T. Waldron et al.
LEUKEMIA (2012)
Survival, prognostic factors and rates of leukemic transformation in 381 untreated patients with MDS and del(5q): A multicenter study
U. Germing et al.
LEUKEMIA (2012)
Long-term follow-up of patients with chronic myeloid leukemia in chronic phase developing sudden blast phase on imatinib therapy
Adisak Tantiworawit et al.
LEUKEMIA & LYMPHOMA (2012)
CBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia
Hideki Makishima et al.
BLOOD (2011)
Role of immune responses in the pathogenesis of low-risk MDS and high-risk MDS: implications for immunotherapy
Shikhar Aggarwal et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Functional Crosstalk between Bmi1 and MLL/Hoxa9 Axis in Establishment of Normal Hematopoietic and Leukemic Stem Cells
Lan-Lan Smith et al.
CELL STEM CELL (2011)
A deep-sequencing study of chronic myeloid leukemia patients in blast crisis (BC-CML) detects mutations in 76.9% of cases
V. Grossmann et al.
LEUKEMIA (2011)
Bmi1 is essential for leukemic reprogramming of myeloid progenitor cells
J. Yuan et al.
LEUKEMIA (2011)
Chronic myeloid leukemia cells refractory/resistant to tyrosine kinase inhibitors are genetically unstable and may cause relapse and malignant progression to the terminal disease state
Tomasz Skorski
LEUKEMIA & LYMPHOMA (2011)
Disease progression mechanism in myelodysplastic syndromes: Insight into the role of the microenvironment
Mariko Ishibashi et al.
LEUKEMIA RESEARCH (2011)
Clinical Effect of Point Mutations in Myelodysplastic Syndromes
Rafael Bejar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Histone methylation in myelodysplastic syndromes
Yue Wei et al.
EPIGENOMICS (2011)
PTEN is a tumor suppressor in CML stem cells and BCR-ABL-induced leukemias in mice
Cong Peng et al.
BLOOD (2010)
BMI1 collaborates with BCR-ABL in leukemic transformation of human CD34+ cells
Aleksandra Rizo et al.
BLOOD (2010)
Histone deacetylase controls adult stem cell aging by balancing the expression of polycomb genes and jumonji domain containing 3
Ji-Won Jung et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
Identification and Characterization of Bmi-1-responding Element within the Human p16 Promoter
Sha Meng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Genetics, Epigenetics, and Leukemia.
Kevin Shannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Characterization of an antagonistic switch between histone H3 lysine 27 methylation and acetylation in the transcriptional regulation of Polycomb group target genes
Diego Pasini et al.
NUCLEIC ACIDS RESEARCH (2010)
The PRC1 Polycomb group complex interacts with PLZF/RARA to mediate leukemic transformation
Hanane Boukarabila et al.
GENES & DEVELOPMENT (2009)
Molecular Pathways Mediating MDS/AML With Focus on AML1/RUNX1 Point Mutations
Yuka Harada et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
PTEN inhibits BMI1 function independently of its phosphatase activity
Catherine Fan et al.
MOLECULAR CANCER (2009)
Many are called MDS cell lines: One is chosen
Hans G. Drexler et al.
LEUKEMIA RESEARCH (2009)
Mechanisms of Disease: Myelodysplastic Syndromes.
Ayalew Tefferi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Polycomb Mediated Epigenetic Silencing and Replication Timing at the INK4a/ARF Locus during Senescence
Hanane Agherbi et al.
PLOS ONE (2009)
RUNX1 DNA-binding mutations and RUNX1-PRDM16 cryptic fusions in BCR-ABL+ leukemias are frequently associated with secondary trisomy 21 and may contribute to clonal evolution and imatinib resistance
Catherine Roche-Lestienne et al.
BLOOD (2008)
Chromatin crosstalk in development and disease: lessons from REST
Lezanne Ooi et al.
NATURE REVIEWS GENETICS (2007)
The polycomb group BMI1 gene is a molecular marker for predicting prognosis of chronic myeloid leukemia
Mohamad Mohty et al.
BLOOD (2007)
Myelodysplastic syndromes and acute leukemia developing after imatinib mesylate therapy for chronic myeloid leukemia
Craig Kovitz et al.
BLOOD (2006)
Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells
Omer H. Yilmaz et al.
NATURE (2006)
Bmi-1 is useful as a novel molecular marker for predicting progression of myelodysplastic syndrome and patient prognosis
K Mihara et al.
BLOOD (2006)
Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells
J Lessard et al.
NATURE (2003)
A candidate X-linked mental retardation gene is a component of a new family of histone deacetylase-containing complexes
MA Hakimi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Unregulated activation of STAT-5, ERK1/2 and c-Fos may contribute to the phenotypic transformation from myelodysplastic syndrome to acute leukaemia
A Kolonics et al.
HAEMATOLOGIA (2001)
分享论文
